Zhang, C., Liang, H., Qin, Y., Tan, X., Su, X., Tian, X., Nong, Y. (2026). A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China perspectives. PLoS ONE. https://doi.org/10.1371/journal.pone.0341154